Search Results

There are 18281 results for: content related to: Clinical–Pathological study of levodopa complications

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Article first published online : 6 JUN 2014, DOI: 10.1002/mds.25914

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Article first published online : 19 JUN 2012, DOI: 10.1002/mds.25051

  3. 2nd World Parkinson Congress Abstracts

    Movement Disorders

    Volume 25, Issue S3, 15 September 2010, Pages: S569–S717,

    Article first published online : 9 SEP 2010, DOI: 10.1002/mds.23386

    Corrected by:

    Erratum: Erratum

    Vol. 25, Issue 15, 2694, Article first published online: 10 NOV 2010

  4. Preventing and controlling dyskinesia in Parkinson's disease—A view of current knowledge and future opportunities

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S585–S598, Peter Jenner

    Article first published online : 9 SEP 2008, DOI: 10.1002/mds.22022

  5. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video-based analysis

    Movement Disorders

    Volume 24, Issue 3, 15 February 2009, Pages: 336–343, C. Warren Olanow, Jean-Michel Gracies, Christopher G. Goetz, A. Jon Stoessl, Thomas Freeman, Jeffrey H. Kordower, James Godbold and Jose A. Obeso

    Article first published online : 12 NOV 2008, DOI: 10.1002/mds.22208

  6. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 8, July 2013, Pages: 1064–1071, C. Warren Olanow, Karl Kieburtz, Olivier Rascol, Werner Poewe, Anthony H. Schapira, Murat Emre, Helena Nissinen, Mika Leinonen, Fabrizio Stocchi and for the Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE-PD) Investigators

    Article first published online : 29 APR 2013, DOI: 10.1002/mds.25364

  7. The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates

    Movement Disorders

    Volume 25, Issue 13, 15 October 2010, Pages: 2084–2093, Tom H. Johnston, Susan H. Fox, Matthew J. Piggott, Juha-Matti Savola and Jonathan M. Brotchie

    Article first published online : 7 SEP 2010, DOI: 10.1002/mds.23172

  8. Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: Effect of dose, frequency of administration, and brain exposure

    Movement Disorders

    Volume 18, Issue 5, May 2003, Pages: 487–495, Lance A. Smith, Michael J. Jackson, Matthew J. Hansard, Eleni Maratos and Peter Jenner

    Article first published online : 28 MAR 2003, DOI: 10.1002/mds.10394

  9. Use of catechol-O-methyltransferase inhibition to minimize L-3,4-dihydroxyphenylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque

    European Journal of Neuroscience

    Volume 37, Issue 5, March 2013, Pages: 831–838, Philippe Huot, Tom H. Johnston, Tessa Snoeren, James B. Koprich, Michael P. Hill, Susan H. Fox and Jonathan M. Brotchie

    Article first published online : 3 JAN 2013, DOI: 10.1111/ejn.12093

  10. Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: Keys to success and roads to failure

    Movement Disorders

    Volume 21, Issue 10, October 2006, Pages: 1578–1594, Susan H. Fox, Anthony E. Lang and Jonathan M. Brotchie

    Article first published online : 27 JUL 2006, DOI: 10.1002/mds.20936

  11. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Article first published online : 21 OCT 2011, DOI: 10.1002/mds.23829

  12. Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa?

    Movement Disorders

    Volume 22, Issue 1, January 2007, Pages: 1–9, John G. Nutt

    Article first published online : 6 SEP 2006, DOI: 10.1002/mds.21060

  13. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Karla Soares-Weiser, Claire B Irving and John Rathbone

    Published Online : 22 APR 2003, DOI: 10.1002/14651858.CD000208

  14. Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets

    Movement Disorders

    Volume 25, Issue 3, 15 February 2010, Pages: 377–384, Kayhan A. Tayarani-Binazir, Michael J. Jackson, Sarah Rose, C. Warren Olanow and Peter Jenner

    Article first published online : 27 JAN 2010, DOI: 10.1002/mds.22960

  15. Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)

    Movement Disorders

    Volume 16, Issue 4, July 2001, Pages: 631–641, Eleni C. Maratos, Michael J. Jackson, Ronald K. B. Pearce and Peter Jenner

    Article first published online : 11 JUL 2001, DOI: 10.1002/mds.1149

  16. You have free access to this content
    Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia

    Journal of Neurochemistry

    Volume 99, Issue 2, October 2006, Pages: 381–392, M. Angela Cenci and Martin Lundblad

    Article first published online : 26 JUL 2006, DOI: 10.1111/j.1471-4159.2006.04124.x

  17. Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations

    Movement Disorders

    Volume 25, Issue 9, 15 July 2010, Pages: 1131–1142, Carlo Colosimo, Pablo Martínez-Martín, Giovanni Fabbrini, Robert A. Hauser, Marcelo Merello, Janis Miyasaki, Werner Poewe, Cristina Sampaio, Olivier Rascol, Glenn T. Stebbins, Anette Schrag and Christopher G. Goetz

    Article first published online : 22 MAR 2010, DOI: 10.1002/mds.23072

  18. Age of Parkinson's disease onset as a predictor for the development of dyskinesia

    Movement Disorders

    Volume 25, Issue 9, 15 July 2010, Pages: 1177–1182, Stephen Ku and Graham A. Glass

    Article first published online : 22 MAR 2010, DOI: 10.1002/mds.23068

  19. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study

    Annals of Neurology

    Volume 68, Issue 1, July 2010, Pages: 18–27, Fabrizio Stocchi, Olivier Rascol, Karl Kieburtz, Werner Poewe, Joseph Jankovic, Eduardo Tolosa, Paulo Barone, Anthony E. Lang and C. Warren Olanow

    Article first published online : 23 APR 2010, DOI: 10.1002/ana.22060

    Corrected by:

    Erratum: Erratum: Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study

    Vol. 68, Issue 3, 412–413, Article first published online: 31 AUG 2010

  20. Effect of histamine H2 receptor antagonism on levodopa–induced dyskinesia in the MPTP-macaque model of Parkinson's disease

    Movement Disorders

    Volume 25, Issue 10, 30 July 2010, Pages: 1379–1390, Tom H. Johnston, Anne van der Meij, Jonathan M. Brotchie and Susan H. Fox

    Article first published online : 22 MAR 2010, DOI: 10.1002/mds.23069